viDA Thereapeutics, Inc. Business Plan

Peer reviewed: 
No, item is not peer reviewed.
Scholarly level: 
Graduate student (Masters)
Date created: 
Pek-Hooi Soh
Beedie School of Business-Segal Graduate School

viDA Therapeutics Inc. (herein called viDA), with headquarters in Vancouver, British Columbia, was incorporated in April of 2008. viDA is a new specialty biotechnology company focused on the discovery, development and commercialization of first-in-class drugs for the treatment of age-related degenerative processes, such as age related wrinkling and hair loss. viDA has chosen a distinct company strategy, focusing strongly on the development and marketing of specialty products. viDA bases its business model in the remarkable and patented discoveries surrounding granzymes. Granzymes have been shown to play a central and pivotal role in the destruction of proteins vital in one’s body anti-aging processes that prevent skin wrinkling and hair loss. viDA is currently looking to secure an initial round of funding of $1.5 million for 2008 and an additional $6 million for 2009 to perform further target identification, target validation, preclinical research and early-stage clinical development. We recommend that viDA seeks the full $7.5 million in Series A an Series B financing simultaneously to ensure adequate funds to meet projected milestones.


MOT MBA Project-Simon Fraser University

Document type: 
Graduating extended essay / Research project
You are free to copy, distribute and transmit this work under the following conditions: You must give attribution to the work (but not in any way that suggests that the author endorses you or your use of the work); You may not use this work for commercial purposes; You may not alter, transform, or build upon this work. Any further uses require the permission of the rights holder (or author if no rights holder is listed). These rights are based on the Creative Commons Attribution-NonCommercial-NoDerivatives License.